Tier 3 — preclinical

Sirt6 reprograms myofibers to oxidative type through CREB-dependent Sox6 suppression

Mi-Young Song, Chang Yeob Han, Young Jae Moon, Ju Hyung Lee, Eun Ju Bae, Byung-Hyun Park
Nature Communications 2022 13(1):1808

Bibliography

PubMed
PMID 35379817
PubMed Central
PMC8980083
Funding
Supported by the Medical Research Center Program (2017R1A5A2015061) and Basic Science Research Program grants 2016R1D1A1B01015213, 2020R1A2C2004761 and 2021R1A2B5B02001462 through the National Research Foundation of Korea.
Competing interests
The authors declared no competing interests.

Study snapshot

DesignIntegrated mouse genetics, pharmacologic SIRT6 activation, skeletal-muscle phenotyping and human exercise-associated expression analysis.
ModelSIRT6 muscle knockout/transgenic mice, activator-treated mice and chronically exercised human muscle observations.
SampleMultiple experimental cohorts; sample sizes vary by experiment.
InterventionGenetic SIRT6 modulation and a pharmacologic SIRT6 activator in mice.
DurationExperiment-dependent.
EndpointsOxidative myofiber composition; mitochondrial oxidative capacity; exercise endurance; CREB/Sox6 signaling; human SIRT6 expression after chronic exercise

What the study showed, in plain terms

This study linked SIRT6 to oxidative muscle-fiber programming. Mouse SIRT6 loss reduced, and overexpression increased, mitochondrial capacity and exercise performance; a SIRT6 activator improved endurance in mice, while chronically exercised humans showed higher muscle SIRT6 expression.

Key findings

SIRT6 promoted oxidative-fiber programming through CREB-dependent suppression of Sox6 and improved endurance in mouse experiments.

What this study can and cannot tell us

The pharmacologic performance result is from mice, and the human data are observational. This does not establish an exercise-performance benefit from SIRT6 activator supplements in people.

Citation network

Articles citing this research paper

3 articles

Biohack Blueprint analyses that reference this study in their evidence base.

Editorial review

Reviewed by the Biohack Blueprint research team

Last verified